The UniverXome subsidiary was established prior to Serina’s reverse merger with AgeX Therapeutics in March 2024 to own the legacy assets of the predecessor company.

A little-known mouse protein disrupts cancer-causing chemical changes to genes associated with human colorectal cancer cells ...

Shelby is an assistant editor for The Scientist. She earned her PhD from West Virginia University in immunology and ...

Over the years I've worked on a lot of projects, and many of them never made it onto the channel. Looking at a few of my ...

PopVax awarded $2M for its patch-delivered mRNA influenza vaccine in collaboration with LTS Lohmann as part of BARDA’s Patch Forward Prize.

The investigational new drug application for the nanoparticle drug SNB-101 has been cleared for small cell lung cancer ...

Tune Therapeutics, a biotech company with headquarters in Seattle and Durham, N.C., raised $175 million in one of the largest ...

The future of burn and wound care is looking fishy—in a good way. New research suggests that a greater variety of fish skins ...

QuantEXAFS, advancing single-atom catalyst analysis by automating data processing and enhancing structural insights.

Catalysts do several surprising things to assist with daily life -- from bread making to turning raw materials into fuels more efficiently. Now, researchers have developed a way to speed up the ...

Advancing Multiple Programs in Areas of Significant Unmet Medical NeedSeveral Milestones Across Clinical Development Pipeline Expected in ...